Your session is about to expire
← Back to Search
Ketorolac Injection for Kidney Stones
Study Summary
This trial is studying whether the drug Ketorolac can help reduce symptoms related to stents.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have kidney or liver problems.I am planning to have a stent placed in my ureter after a procedure for kidney stones.I have been taking NSAIDs regularly for the last month, but I can take daily Aspirin 81 mg.I am currently taking steroid medication.I am taking prescription anti-inflammatory medication.I have a stomach or intestinal ulcer.You have a tube in your ureter already.I do not have an active urinary tract infection.I need a procedure for stones in both kidneys.I have a blockage or narrowing in my ureter not caused by kidney stones.I am over 18 and can give my consent.
- Group 1: Intervention Group - Ketorlac (NSAID)
- Group 2: Placebo Group - Normal Saline
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have signed up to partake in this research?
"Affirmative, according to the information held on clinicaltrials.gov this study is actively looking for participants. It was initially posted on July 31st 2018 and last updated November 22nd 2022. They require 36 patients from a single medical centre."
What additional testing has been carried out in relation to Intervention Group - Ketorlac (NSAID)?
"Currently, 8 Phase 3 trials involving the use of ketorlac (NSAID) are underway. Most studies have been established in Los Angeles but there are 57 additional sites participating in these clinical investigations."
What indications has Ketorlac (NSAID) been found to be most efficacious in treating?
"Intervention Group - Ketorlac (NSAID) can be administered to alleviate ocular itching, pain, and the formation of nerve block."
Are there any existing opportunities for participation in this research?
"According to clinicaltrials.gov, this research endeavor is currently recruiting participants; the trial was first advertised on July 31st 2018 and was last revised November 22nd 2022."
Share this study with friends
Copy Link
Messenger